Aurantiamide acetate
Aurantiamide acetate (TMC-58A) is a selective and orally active cathepsin inhibitor isolated from Portulaca oleracea L. Aurantiamide acetate has anti-inflammatory activities and can be used for the study of inflammatory diseases[1][2].
Product Specifications
CAS Number
56121-42-7
Product Name Alternative
Asperglaucide
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Cathepsin
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/aurantiamide-acetate.html
Purity
99.85
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(N[C@H](COC(C)=O)CC1=CC=CC=C1)[C@@H](NC(C2=CC=CC=C2)=O)CC3=CC=CC=C3
Molecular Formula
C27H28N2O4
Molecular Weight
444.52
Precautions
H302, H315, H319, H335
References & Citations
[1]K Isshiki, et al. Aurantiamide Acetate, a Selective Cathepsin Inhibitor, Produced by Aspergillus Penicilloides. Biosci Biotechnol Biochem. 2001 May;65 (5) :1195-7.|[2]Chi-Su Yoon, et al. Anti-neuroinflammatory Effect of Aurantiamide Acetate From the Marine Fungus Aspergillus Sp. SF-5921: Inhibition of NF-κB and MAPK Pathways in Lipopolysaccharide-Induced Mouse BV2 Microglial Cells.Int Immunopharmacol. 2014 Dec;23 (2) :568-74.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Cathepsin L
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY431354 100 µg
GM CSF Receptor alpha (CSF2RA) (NM_001161531) Human Over-expression Lysate
Sign In for Pricing
View Details 
LY431796 100 µg
Prolactin (PRL) (NM_001163558) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC680091-500 1x 500 µL
Fibronectin (2755-8), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details